Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Hyperfine, Inc. HYPR

Healthcare  —  Medical Devices
0.81 0.01 1.25% as of 25 Sep
Market cap
$84.4M
P/E
0.0×
Cash Flow Champion (3y) Revenue Champion (5y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Hyperfine, Inc. (HYPR) Business Profile

Updated before January 2025

Company Overview

Hyperfine, Inc. (HYPR) is a pioneering medical technology company that specializes in innovative imaging solutions. Founded in 2014 by Dr. Jonathan Rothberg, a renowned scientist and entrepreneur, Hyperfine is headquartered in Guilford, Connecticut, USA. The company was established with the mission to democratize access to advanced medical imaging technologies, making them more affordable, portable, and accessible to healthcare providers worldwide.

Dr. Rothberg, known for his groundbreaking work in genomics and medical technology, envisioned a future where medical imaging could be brought to the bedside, eliminating the need for expensive and immobile MRI systems. The company’s leadership team includes seasoned professionals with extensive experience in healthcare, technology, and business management. Key executives include Dave Scott, who serves as the CEO, and other leaders who bring expertise in engineering, clinical research, and operations.

Core Business Segments

Hyperfine focuses on the development and commercialization of portable medical imaging solutions. Its flagship product is the Swoop® Portable MR Imaging System, which has revolutionized the field of magnetic resonance imaging (MRI). Below are the core business segments:

Portable MRI Systems

  • Swoop® Portable MR Imaging System: This is the world’s first FDA-cleared portable MRI system. It is designed to be wheeled directly to a patient’s bedside, enabling immediate imaging in critical care settings such as emergency rooms, intensive care units, and rural healthcare facilities. The Swoop system is compact, easy to use, and significantly more affordable than traditional MRI systems.

Software and AI Solutions

  • Advanced Imaging Software: Hyperfine integrates artificial intelligence (AI) and machine learning into its imaging systems to enhance diagnostic accuracy and streamline workflows.
  • Cloud-Based Data Management: The company offers cloud-based solutions for storing, sharing, and analyzing imaging data, ensuring seamless integration with existing healthcare IT systems.

Service and Support

  • Maintenance and Training: Hyperfine provides comprehensive maintenance services and training programs to ensure optimal performance of its imaging systems.
  • Customer Support: The company offers 24/7 customer support to address technical issues and provide guidance to healthcare professionals.

Business Model

Hyperfine operates on a hybrid business model that combines product sales, subscription-based services, and long-term partnerships with healthcare providers. The company generates revenue through the following channels:

  1. Product Sales: Direct sales of the Swoop® Portable MR Imaging System to hospitals, clinics, and other healthcare facilities.
  2. Subscription Services: Recurring revenue from software subscriptions, including AI-powered diagnostic tools and cloud-based data management solutions.
  3. Service Contracts: Revenue from maintenance, training, and customer support services.
  4. Partnerships: Collaborations with healthcare organizations, research institutions, and government agencies to expand the adoption of portable imaging technologies.

Strategic Direction

Hyperfine is committed to driving innovation in medical imaging and expanding its global footprint. The company’s strategic priorities include:

  1. Product Development: Continuously improving the Swoop® system and developing new portable imaging solutions for other modalities, such as ultrasound and CT scans.
  2. Market Expansion: Increasing penetration in emerging markets where access to traditional MRI systems is limited.
  3. Sustainability Goals: Reducing the environmental impact of medical imaging by designing energy-efficient and recyclable products.
  4. Research and Innovation: Investing in R&D to integrate advanced technologies like AI, machine learning, and robotics into its imaging systems.

Competitive Landscape

Hyperfine operates in a competitive market with several established players and emerging startups. Key competitors include:

  • GE Healthcare: A global leader in medical imaging technologies, offering a wide range of MRI systems.
  • Siemens Healthineers: Known for its high-performance MRI systems and advanced imaging software.
  • Philips Healthcare: A major player in the medical imaging market, focusing on innovation and patient-centric solutions.
  • Portable Imaging Startups: Companies like Butterfly Network and Nanox are also developing portable imaging solutions, posing competition to Hyperfine.

Despite the competition, Hyperfine differentiates itself through its focus on portability, affordability, and accessibility.

Risk Factors

Hyperfine faces several risks that could impact its business operations and financial performance:

  1. Market Dependence: Reliance on the success of the Swoop® system as its primary revenue driver.
  2. Regulatory Challenges: Compliance with stringent regulatory requirements for medical devices in different countries.
  3. Supply Chain Disruptions: Dependence on a global supply chain for components and materials, which could be affected by geopolitical tensions or natural disasters.
  4. Competition: Intense competition from established players and new entrants in the medical imaging market.
  5. Economic Factors: Economic downturns or budget constraints in healthcare systems could affect purchasing decisions.

Recent Developments

Hyperfine has made significant strides in recent years, including:

  • FDA Clearance: Obtaining FDA clearance for new features and applications of the Swoop® system.
  • Global Expansion: Entering new markets in Asia, Europe, and Latin America.
  • Partnerships: Collaborating with leading healthcare institutions to conduct clinical studies and validate the efficacy of its imaging solutions.
  • Technological Advancements: Launching updates to its imaging software, incorporating AI-driven diagnostic tools.

Investment Considerations

Strengths

  • Innovative Technology: First-mover advantage in the portable MRI market.
  • Growing Market Demand: Increasing demand for affordable and accessible imaging solutions.
  • Strong Leadership: Experienced management team with a track record of success.
  • Scalability: Potential to expand into new markets and product categories.

Risks

  • High R&D Costs: Significant investment required for product development and innovation.
  • Market Uncertainty: Dependence on the adoption of portable imaging technologies.
  • Regulatory Risks: Challenges in obtaining and maintaining regulatory approvals.

Conclusion

Hyperfine, Inc. is at the forefront of transforming medical imaging with its innovative and accessible solutions. The company’s focus on portability, affordability, and advanced technology positions it as a leader in the healthcare industry. With a strong commitment to innovation and global expansion, Hyperfine is well-positioned for future growth, despite the challenges it faces. Investors should consider the company’s strengths and risks when evaluating its potential as an investment opportunity.